Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization.

Patients with heart disease are frequently treated with supplemental oxygen. Although oxygen can exhibit vasoactive properties in many vascular beds, its effects on the coronary circulation have not been fully characterized. To examine whether supplemental oxygen administration affects coronary blood flow (CBF) in a clinical setting, we measured in 18 patients with stable coronary heart disease the effects of breathing 100% oxygen by face mask for 15 min on CBF (via coronary Doppler flow wire), conduit coronary diameter, CBF response to intracoronary infusion of the endothelium-dependent dilator ACh and to the endothelium-independent dilator adenosine, as well as arterial and coronary venous concentrations of the nitric oxide (NO) metabolites nitrotyrosine, NO(2)(-), and NO(3)(-). Relative to breathing room air, breathing of 100% oxygen increased coronary resistance by approximately 40%, decreased CBF by approximately 30%, increased the appearance of nitrotyrosine in coronary venous plasma, and significantly blunted the CBF response to ACh. Oxygen breathing elicited these changes without affecting the diameter of large-conduit coronary arteries, coronary venous concentrations of NO(2)(-) and NO(3)(-), or the coronary vasodilator response to adenosine. Administering supplemental oxygen to patients undergoing cardiac catheterization substantially increases coronary vascular resistance by a mechanism that may involve oxidative quenching of NO within the coronary microcirculation.

[1]  Rafael Radi,et al.  Nitric oxide, oxidants, and protein tyrosine nitration , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Gladwin,et al.  Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation , 2003, Nature Medicine.

[3]  S. Hazen,et al.  Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. , 2003, JAMA.

[4]  G. Newton,et al.  Vitamin C prevents hyperoxia-mediated vasoconstriction and impairment of endothelium-dependent vasodilation. , 2002, American journal of physiology. Heart and circulatory physiology.

[5]  D. Citrin,et al.  A Chemical Perspective on the Interplay Between NO, Reactive Oxygen Species, and Reactive Nitrogen Oxide Species , 2002, Annals of the New York Academy of Sciences.

[6]  T. Rassaf,et al.  Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Ceriello,et al.  Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress , 2001, Diabetologia.

[8]  L. Beilin,et al.  Advanced glycation end-products: a review , 2001, Diabetologia.

[9]  W. Sessa,et al.  Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs. , 2000, American journal of physiology. Heart and circulatory physiology.

[10]  F. Recchia,et al.  NO metabolites accumulate in erythrocytes in proportion to carbon dioxide and bicarbonate concentration. , 2000, American journal of physiology. Heart and circulatory physiology.

[11]  S. Archer,et al.  Coronary nitric oxide production in response to exercise and endothelium-dependent agonists. , 2000, Circulation.

[12]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[13]  D. Henrion,et al.  Self-protection by cardiac myocytes against hypoxia and hyperoxia. , 1999, Circulation research.

[14]  E. Marbán,et al.  Molecular and cellular mechanisms of myocardial stunning. , 1999, Physiological reviews.

[15]  G. Newton,et al.  Hemodynamic and biochemical effects of 100% oxygen breathing in humans. , 1999, Canadian journal of physiology and pharmacology.

[16]  F. Recchia,et al.  Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. , 1998, Circulation research.

[17]  G. Jennings,et al.  The failing human heart does not release nitrogen oxides. , 1998, Life sciences.

[18]  T. Miyazaki,et al.  An assay method for nitric oxide-related compounds in whole blood. , 1997, Analytical biochemistry.

[19]  L. Sinoway,et al.  Effects of supplemental oxygen on forearm vasodilation in humans. , 1997, Journal of applied physiology.

[20]  D. Wink,et al.  The Nitric Oxide/Superoxide Assay , 1997, The Journal of Biological Chemistry.

[21]  E. Troncy,et al.  Effects of reducing reagents and temperature on conversion of nitrite and nitrate to nitric oxide and detection of NO by chemiluminescence. , 1997, Clinical chemistry.

[22]  D. Green,et al.  Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. , 1997, Circulation.

[23]  X. Xu,et al.  Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. , 1996, Circulation research.

[24]  J. Stamler,et al.  S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control , 1996, Nature.

[25]  T. Hintze,et al.  Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. , 1995, Circulation.

[26]  J. Hodgson,et al.  Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. , 1994, Journal of the American College of Cardiology.

[27]  A Mebazaa,et al.  Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. , 1993, The American journal of physiology.

[28]  A. Sharkey,et al.  Cardiac endothelial cells modulate contractility of rat heart in response to oxygen tension and coronary flow. , 1993, Circulation research.

[29]  M. Hori,et al.  Adenosine, the Heart, and Coronary Circulation , 1991, Hypertension.

[30]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[31]  V. Miller,et al.  Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow. , 1988, The American journal of physiology.

[32]  P. Vanhoutte,et al.  Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. , 1986, The American journal of physiology.

[33]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[34]  J. Balligand,et al.  Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  B. Chance,et al.  The relation of free radical production to hyperoxia. , 1986, Annual review of physiology.

[36]  S. Bondurant,et al.  Effects of oxygen breathing on the heart rate, blood pressure, and cardiac index of normal men--resting, with reactive hyperemia, and after atropine. , 1962, The Journal of clinical investigation.